Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade

Cited by (1,000)

Items 401–500 of 1,000

1. Recent Advances and Future Prospects in Immune Checkpoint (ICI)-Based Combination Therapy for Advanced HCC
   Yawen Dong, Jeffrey Sum Lung Wong, Ryohichi Sugimura, Ka On Lam, Bryan K. Li, Gin Wai Kwok, Roland Ching-Yu Leung, Joanne Wing Yan Chiu, Tan To Cheung, Thomas C. C. Yau · 2021 · Cancers
2. p16INK4a Regulates Cellular Senescence in PD-1-Expressing Human T Cells
   Valérie Janelle, Mathieu Neault, Marie‐Ève Lebel, Dave Maurice De Sousa, Salix Boulet, Ludovic Durrieu, Cédric Carli, Chloé Muzac, Sébastien Lemieux, Nathalie Labrecque et al. · 2021 · Frontiers in Immunology
3. Therapeutic resistance in pancreatic ductal adenocarcinoma: Current challenges and future opportunities
   Aditi Jain, Vikas Bhardwaj · 2021 · World Journal of Gastroenterology
4. Insights Into Persistent HIV-1 Infection and Functional Cure: Novel Capabilities and Strategies
   Tram M. Ta, Sajjaf Malik, Elizabeth M. Anderson, Amber D. Jones, Jocelyn Perchik, Maryann Freylikh, Luca Sardo, Zackary A. Klase, Taisuke Izumi · 2022 · Frontiers in Microbiology
5. Molecular dissection of CD8+ T cell dysfunction
   Chao Wang, Meromit Singer, A. Anderson · 2017 · Trends in immunology
6. HBV Immune-Therapy: From Molecular Mechanisms to Clinical Applications
   Carolina Boni, Valeria Barili, Greta Acerbi, Marzia Rossi, Andrea Lorenzo Vecchi, Diletta Laccabue, Amalia Penna, Gabriele Missale, Carlo I. Ferrari, Paola Fisicaro · 2019 · International Journal of Molecular Sciences
7. Epigenetics of T cell aging
   Goronzy, Jörg J, Hu, Bin, Kim, Chulwoo, Jadhav, Rohit R, Weyand, Cornelia M · 2018 · Journal of Leukocyte Biology
8. Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy
   Pavan Bachireddy, Elham Azizi, Cassandra Burdziak, Vinhkhang N. Nguyen, Christina S. Ennis, Katie Maurer, Cameron Y. Park, Zi-Ning Choo, Shuqiang Li, Satyen Harish Gohil et al. · 2021 · Cell Reports
9. The Crossroads of Cancer Epigenetics and Immune Checkpoint Therapy
   Goran Micevic, Marcus Bosenberg, Qin Yan · 2022 · Clinical Cancer Research
10. Sodium chloride in the tumor microenvironment enhances T cell metabolic fitness and cytotoxicity
    Dominik Soll, Chang-Feng Chu, Shan Sun, Veronika Lutz, Mahima Arunkumar, Mariam A. Gachechiladze, Sascha Schäuble, Maha Alissa-Alkhalaf, Trang T. T. Nguyen, Michelle‐Amirah Khalil et al. · 2024 · Nature Immunology
11. Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survival
    Geoffrey J. Markowitz, Lauren S. Havel, Michael J. P. Crowley, Yi Ban, Sharrell B. Lee, Jennifer S. Thalappillil, Navneet Narula, Bhavneet Bhinder, Olivier Elemento, Stephen T. C. Wong et al. · 2018 · JCI Insight
12. A bilateral tumor model identifies transcriptional programs associated with patient response to immune checkpoint blockade
    Ivy X. Chen, Kathleen Newcomer, Kristen E. Pauken, Vikram R. Juneja, Kamila Naxerova, Michelle W. Wu, Matthias Pinter, Debattama R. Sen, Meromit Singer, Arlene H. Sharpe et al. · 2020 · Proceedings of the National Academy of Sciences
13. The therapeutic landscape of hepatocellular carcinoma
    Suchira Gallage, Maria Garcia Beccaria, Marta Szydlowska, Mohammad Rahbari, Raphael U. Mohr, Frank Tacke, Mathias F Heikenwälder · 2021 · Med
14. CD4+ T-cell epitope-based heterologous prime-boost vaccination potentiates anti-tumor immunity and PD-1/PD-L1 immunotherapy
    Minglu Xiao, Luoyingzi Xie, Guoshuai Cao, Shun� Lei, Pengcheng Wang, Zhengping Wei, Yuan Luo, Jingyi Fang, Xingxing Yang, Qizhao Huang et al. · 2022 · Journal for ImmunoTherapy of Cancer
15. Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta
    Richard A. O’Connor, Begoña Roman Martinez, Lilian Koppensteiner, Layla Mathieson, Ahsan R. Akram · 2023 · Frontiers in Immunology
16. Immuno-oncology-101: overview of major concepts and translational perspectives
    Bertrand Allard, Sandrine Aspeslagh, Soizic Garaud, Floriane Dupont, Cinzia Solinas, Marleen Kok, Bertrand Routy, Christos P. Sotiriou, John Stagg, Laurence Buisseret · 2018 · Seminars in Cancer Biology
17. Targeting PD-1 or PD-L1 in Metastatic Kidney Cancer: Combination Therapy in the First-Line Setting
    David Henry Aggen, Charles G. Drake, Brian I. Rini · 2020 · Clinical Cancer Research
18. Anti-PD-1/PD-L1 Based Combination Immunotherapy to Boost Antigen-Specific CD8+ T Cell Response in Hepatocellular Carcinoma
    Julia Peña-Asensio, H. Calvo, M. Torralba, J. Miquel, E. Sanz-de-Villalobos, J. Larrubia · 2021 · Cancers
19. Knowns and Unknowns about CAR-T Cell Dysfunction
    Aleksei Titov, Yaroslav Kaminskiy, Irina Ganeeva, Ekaterina Zmievskaya, Aygul Valiullina, Aygul Rakhmatullina, Alexey Petukhov, Мифтахова Регина Рифкатовна, Albert Anatolyevich Rizvanov, Emil Bulatov · 2022 · Cancers
20. Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance
    Dhivya Sridaran, Surbhi Chouhan, Kiran N. Mahajan, Arun Renganathan, Cody Weimholt, Shambhavi Bhagwat, Melissa Andrea Reimers, Eric H. Kim, Manish Kumar Thakur, Muhammad Azeem Saeed et al. · 2022 · Nature Communications
21. Molecular Mechanisms Governing CD8 T Cell Differentiation and Checkpoint Inhibitor Response in Cancer
    Lisa Rausch, Axel Kallies · 2025 · Annual Review of Immunology
22. Heterogeneity of HBV-Specific CD8+ T-Cell Failure: Implications for Immunotherapy
    Kathrin Heim, Christoph Neumann‐Haefelin, Robert Thimme, Maike Hofmann · 2019 · Frontiers in Immunology
23. Re-defining T-Cell Exhaustion: Subset, Function, and Regulation
    Se Jin Im, Sang‐Jun Ha · 2020 · Immune Network
24. A single-cell map of dynamic chromatin landscapes of immune cells in renal cell carcinoma
    Nikos Kourtis, Qingqing Wang, Bei Wang, Erin M. Oswald, Christina Adler, Samvitha Cherravuru, Evangelia Malahias, Lance Zhang, Jacquelynn Golubov, Qiaozhi Wei et al. · 2022 · Nature Cancer
25. Harnessing CD8 T cell responses using PD-1–IL-2 combination therapy
    Masao Hashimoto, Suresh S. Ramalingam, Rafi Ahmed · 2023 · Trends in cancer
26. CD8+ T Cell Responses during HCV Infection and HCC
    Maike Hofmann, Catrin Tauber, Nina Hensel, Robert Thimme · 2021 · Journal of Clinical Medicine
27. Metabolic regulation of T cells in the tumor microenvironment by nutrient availability and diet
    Steven Zhao, Ronal M. Peralta, Natalia Avina-Ochoa, Greg M. Delgoffe, Susan M. Kaech · 2021 · Seminars in Immunology
28. Immune Checkpoint Inhibitors in the Treatment of Melanoma: From Basic Science to Clinical Application
    Surface Oncology, 50 Hampshire Street, 8th Floor, Cambridge, MA 02139, USA, Matthew P. Rausch, Karen Taraszka Hastings · 2017 · Codon Publications eBooks
29. PD-1/PD-L1 expression and interaction by automated quantitative immunofluorescent analysis show adverse prognostic impact in patients with diffuse large B-cell lymphoma having T-cell infiltration: a study from the International DLBCL Consortium Program
    Ling Li, Ruifang Sun, Yi Miao, Thai H. Tran, Lisa G. Adams, Nathan Roscoe, Bing Xu, Ganiraju C. Manyam, Xiaohong Tan, Hongwei Zhang et al. · 2019 · Modern Pathology
30. Helpless Priming Sends CD8+ T Cells on the Road to Exhaustion
    Julia Busselaar, Sun Tian, Hans van Eenennaam, Jannie G. Borst · 2020 · Frontiers in Immunology
31. Pre-encoded responsiveness to type I interferon in the peripheral immune system defines outcome of PD1 blockade therapy
    Giselle M. Boukhaled, Ramy Gadalla, Heidi J. Elsaesser, Diala Abd-Rabbo, Rene Quevedo, S.Y. Cindy Yang, Mengdi Guo, Ben X. Wang, Babak Noamani, Diana Gray et al. · 2022 · Nature Immunology
32. Immune cellular components and signaling pathways in the tumor microenvironment
    Sasitorn Yenyuwadee, Konstantinos Aliazis, Qi Wang, Anthos Christofides, Rushil Shah, Nikolaos Patsoukis, Vassiliki A. Boussiotis · 2022 · Seminars in Cancer Biology
33. Technology meets TILs: Deciphering T cell function in the -omics era
    William H. Hudson, Andreas Wieland · 2022 · Cancer Cell
34. VISTA Targeting of T-cell Quiescence and Myeloid Suppression Overcomes Adaptive Resistance
    Evelien Schaafsma, Walburga Croteau, Mohamed A. ElTanbouly, Elizabeth C. Nowak, Nicole C. Smits, Jie Deng, Aurélien Sarde, Cecilia A. Webber, Dina Rabadi, Chao Cheng et al. · 2022 · Cancer Immunology Research
35. Comprehensive single-cell aging atlas of healthy mammary tissues reveals shared epigenomic and transcriptomic signatures of aging and cancer
    Brittany Lynn Angarola, Siddhartha M. Sharma, Neerja Katiyar, Hyeon Gu Kang, Djamel Nehar-Belaid, Sung‐Hee Park, Rachel Gott, Giray Naim Eryilmaz, Mark A. LaBarge, Karolina Palucka et al. · 2024 · Nature Aging
36. Continuous expression of TOX safeguards exhausted CD8 T cell epigenetic fate
    Yinghui Huang, Shin Foong Ngiow, Amy E. Baxter, Sasikanth Manne, Simone L. Park, Jennifer E. Wu, Omar Khan, Josephine Ruth Giles, E. John Wherry · 2025 · Science Immunology
37. Hypothesis: stimulation of trained immunity as adjunctive immunotherapy in cancer
    Mihai Gheorghe Netea, Leo A. B. Joosten, Jos W. M. van der Meer · 2017 · Journal of Leukocyte Biology
38. Mechanisms Governing Immunotherapy Resistance in Pancreatic Ductal Adenocarcinoma
    Zoe C. Schmiechen, Ingunn M. Stromnes · 2021 · Frontiers in Immunology
39. Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control
    Sarah A. Weiss, Amy Y. Huang, Megan E. Fung, Daniela Martínez, Chang-Yu Chen, Thomas J. LaSalle, Brian C. Miller, Christopher D. Scharer, Mudra Hegde, Thao H. Nguyen et al. · 2024 · Nature Immunology
40. Coexpression of Inhibitory Receptors Enriches for Activated and Functional CD8+ T Cells in Murine Syngeneic Tumor Models
    Huizhong Xiong, Stephanie Mittman, Ryan Rodriguez, Patricia Pacheco-Sanchez, Марина Москаленко, Yagai Yang, Justin Elstrott, Alex T. Ritter, Sören Müller, Dorothee Nickles et al. · 2019 · Cancer Immunology Research
41. The costimulatory activity of Tim-3 requires Akt and MAPK signaling and its recruitment to the immune synapse
    Shunsuke Kataoka, Priyanka Manandhar, Judong Lee, Creg J. Workman, Hridesh Banerjee, Andrea L. Szymczak-Workman, Michael Kvorjak, Jason J. Lohmueller, Larry Kane · 2021 · Science Signaling
42. Coadministration of iRGD peptide with ROS-sensitive nanoparticles co-delivering siFGL1 and siPD-L1 enhanced tumor immunotherapy
    Wenjun Wan, Gui Huang, Yu Wang, Yan Tang, Hui Li, Changhao Jia, Yang Liu, Beng-gang You, Xuenong Zhang · 2021 · Acta Biomaterialia
43. Breaking Bottlenecks for the TCR Therapy of Cancer
    Gaissmaier, Lena, Elshiaty, Mariam, Christopoulos, Petros · 2020 · Cells
44. DNA Methylation in T-Cell Development and Differentiation
    Luis O. Correa, Martha S. Jordan, Shannon A. Carty · 2020 · Critical Reviews in Immunology
45. T cell receptor and IL-2 signaling strength control memory CD8+ T cell functional fitness via chromatin remodeling
    Shu Shien Chin, Erik Guillen, Laurent Chorro, Sooraj R. Achar, Karina Ng, Susanne G. Oberle, Francesca Alfei, Dietmar Zehn, Grégoire Y Altan-Bonnet, Fabien Delahaye et al. · 2022 · Nature Communications
46. Emerging Epigenetic‐Based Nanotechnology for Cancer Therapy: Modulating the Tumor Microenvironment
    Jiaxin Zhang, Leaf Huang, Guangbo Ge, Kaili Hu · 2023 · Advanced Science
47. IL-7R licenses a population of epigenetically poised memory CD8 + T cells with superior antitumor efficacy that are critical for melanoma memory
    Goran Micevic, Andrew Daniels, Karine Flem Karlsen, Koonam Park, Ronan Talty, Meaghan K. McGeary, Haris Mirza, Holly N. Blackburn, Esen Sefik, Julie F. Cheung et al. · 2023 · Proceedings of the National Academy of Sciences
48. Type I interferons induce an epigenetically distinct memory B cell subset in chronic viral infection
    Lucy Cooper, Hui Min Xu, Jack Polmear, Liam Kealy, Christopher W. Szeto, Ee Shan Pang, Mansi Gupta, Alana Kirn, Justin J. Taylor, Katherine Jackson et al. · 2024 · Immunity
49. ACLY and ACSS2 link nutrient-dependent chromatin accessibility to CD8 T cell effector responses
    Irem Kaymak, McLane J. Watson, Brandon M. Oswald, Shixin Ma, Benjamin K. Johnson, Lisa M. DeCamp, Batsirai M. Mabvakure, Katarzyna Müller Luda, Eric H. Ma, Kin H. Lau et al. · 2024 · The Journal of Experimental Medicine
50. Succinate preserves CD8+ T cell fitness to augment antitumor immunity
    Kaili Ma, Hongcheng Cheng, Lin Wang, Han Xiao, Fenghua Liu, Yu Ting Yang, Zhen Xiao, Kun Tang, Shicheng Li, Gang Wang et al. · 2025 · Immunity
51. Hepatitis B Virus-Specific CD8+ T Cells Maintain Functional Exhaustion after Antigen Reexposure in an Acute Activation Immune Environment
    Qin Wang, Wen Pan, Yanan Liu, Jinzhuo Luo, Dan Yan Zhu, Yinping Lu, Xuemei Feng, Xuecheng Yang, Ulf Dittmer, Mengji Lu et al. · 2018 · Frontiers in Immunology
52. Mechanisms of Primary and Secondary Resistance to Immune Checkpoint Inhibitors in Cancer
    Tiffany Seto, Danny L. Sam, Minggui Pan · 2019 · Medical Sciences
53. Use of Mass Cytometry to Profile Human T Cell Exhaustion
    Frances Winkler, Bertram Bengsch · 2020 · Frontiers in Immunology
54. Persistent expansion and Th1-like skewing of HIV-specific circulating T follicular helper cells during antiretroviral therapy
    Julia Niessl, Amy E. Baxter, Antigoni Morou, Elsa Brunet‐Ratnasingham, Gérémy Sannier, Gabrielle Gendron‐Lepage, Jonathan Richard, Gloria-Gabrielle Ortega-Delgado, Nathalie Brassard, Isabelle Turcotte et al. · 2020 · EBioMedicine
55. Exhaustion of the CD8+ T Cell Compartment in Patients with Mutations in Phosphoinositide 3-Kinase Delta
    M. Wentink, Yvonne M. Mueller, V. Dalm, G. Driessen, P. V. van Hagen, J. V. van Montfrans, M. van der Burg, P. Katsikis · 2018 · Frontiers in Immunology
56. Is There a Positive Side to T Cell Exhaustion?
    Graham Pawelec · 2019 · Frontiers in Immunology
57. T cell exhaustion is associated with antigen abundance and promotes transplant acceptance
    Dawei Zou, Yulin Dai, Xiaolong Zhang, Guohua Wang, Xiang Xiao, Peilin Jia, X.C. Li, Zhiyong Guo, Wenhao Chen · 2020 · American Journal of Transplantation
58. Glycogen synthase kinase 3 inhibition lowers PD-1 expression, promotes long-term survival and memory generation in antigen-specific CAR-T cells
    Sadhak Sengupta, Steven C. Katz, Sudarshana Sengupta, Prakash Sampath · 2018 · Cancer Letters
59. Epigenetic remodeling of the immune landscape in cancer: therapeutic hurdles and opportunities
    Feng‐Ming Tien, Hsuan‐Hsuan Lu, Shu‐Yung Lin, Hsing-Chen Tsai · 2023 · Journal of Biomedical Science
60. IL1R2 Blockade Alleviates Immunosuppression and Potentiates Anti-PD-1 Efficacy in Triple-Negative Breast Cancer
    Jie Xia, Lixing Zhang, Xilei Peng, Juchuanli Tu, Siqin Li, Xueyan He, Fengkai Li, Jiankun Qiang, Haonan Dong, Qiaodan Deng et al. · 2024 · Cancer Research
61. The Potential of Donor T-Cell Repertoires in Neoantigen-Targeted Cancer Immunotherapy
    Terhi Kärpänen, Johanna Olweus · 2017 · Frontiers in Immunology
62. EZH2 as a Regulator of CD8+ T Cell Fate and Function
    Christopher J. Stairiker, Graham D. Thomas, Shahram Salek‐Ardakani · 2020 · Frontiers in Immunology
63. T Cell Memory in Infection, Cancer, and Autoimmunity
    Vincenzo Barnaba · 2022 · Frontiers in Immunology
64. T cell toxicity of HIV latency reversing agents
    Manzhi Zhao, Elisa De Crignis, Casper Rokx, Annelies Verbon, Teun van Gelder, Tokameh Mahmoudi, Peter D. Katsikis, Yvonne M. Mueller · 2018 · Pharmacological Research
65. Rebalancing TGFβ1/BMP signals in exhausted T cells unlocks responsiveness to immune checkpoint blockade therapy
    Abbey A. Saadey, Amir Yousif, Nicole Osborne, Roya Shahinfar, Yulin Chen, Brooke Laster, Meera Rajeev, Parker Bauman, Amy Webb, Hazem E. Ghoneim · 2022 · Nature Immunology
66. Atezolizumab for the treatment of non-small cell lung cancer
    Fernando Costa Santini, Charles M. Rudin · 2017 · Expert Review of Clinical Pharmacology
67. Modulation of Antitumor Immunity with Histone Deacetylase Inhibitors
    Tyler R. McCaw, Troy D. Randall, Andres Forero, Donald J. Buchsbaum · 2017 · Immunotherapy
68. Early programming of CD8 + T cell response by the orphan nuclear receptor NR4A3
    Livia Odagiu, Salix Boulet, Dave Maurice De Sousa, Jean‐François Daudelin, Sandrine Nicolas, Nathalie Labrecque · 2020 · Proceedings of the National Academy of Sciences
69. Efficacy of Decitabine plus Anti-PD-1 Camrelizumab in Patients with Hodgkin Lymphoma Who Progressed or Relapsed after PD-1 Blockade Monotherapy
    Chunmeng Wang, Yang Liu, Liang Dong, Xiang Li, Qingming Yang, Malcolm V. Brock, Qian Mei, Jiejie Liu, Meixia Chen, Fengxia Shi et al. · 2021 · Clinical Cancer Research
70. Unleashing the Therapeutic Potential of CAR-T Cell Therapy Using Gene-Editing Technologies.
    In-Young Jung, Jungmin Lee · 2018 · Europe PMC (PubMed Central)
71. Transcriptional and epigenetic regulation of T cell hyporesponsiveness
    Renata M. Pereira, Patrick G. Hogan, Anjana Rao, Gustavo Martínez · 2017 · Journal of Leukocyte Biology
72. Epigenetic changes in fibroblasts drive cancer metabolism and differentiation
    Rajeev Mishra, Subhash Haldar, Surabhi Suchanti, Neil A. Bhowmick · 2019 · Endocrine Related Cancer
73. Resistance to immune checkpoint blockade: Mechanisms, counter-acting approaches, and future directions
    Alexander F. Haddad, Jacob S. Young, Sabraj A. Gill, Manish Kumar Aghi · 2022 · Seminars in Cancer Biology
74. Relapse after CAR-T cell therapy in B-cell malignancies: challenges and future approaches
    Tianning Gu, Meng Zhu, He Huang, Yongxian Hu · 2022 · Journal of Zhejiang University SCIENCE B
75. Synergy of Immune Checkpoint Blockade with a Novel Synthetic Consensus DNA Vaccine Targeting TERT
    Elizabeth K. Duperret, Megan C. Wise, Aspen Trautz, Daniel O. Villarreal, Bernadette Ferraro, Jewell N. Walters, Jian Yan, Amir Sada Khan, Emma L. Masteller, Laurent M. P. F. Humeau et al. · 2017 · Molecular Therapy
76. Reversal of T Cell Exhaustion by the First Donor Lymphocyte Infusion Is Associated with the Persistently Effective Antileukemic Responses in Patients with Relapsed AML after Allo-HSCT
    Long Liu, Ying‐Jun Chang, Lan‐Ping Xu, Xiaohui Zhang, Yu Wang, Kai‐Yan Liu, Xiao-Jun Huang · 2018 · Transplantation and Cellular Therapy
77. Acquired Resistance to PD-1/PD-L1 Blockade in Lung Cancer: Mechanisms and Patterns of Failure
    Ranjan Pathak, Rebecca R. Pharaon, Atish Ranjan Mohanty, Victoria Meucci Villaflor, Ravi Salgia, Erminia Massarelli · 2020 · Cancers
78. Schrödinger’s T Cells: Molecular Insights Into Stemness and Exhaustion
    Nancy M. Gonzalez, Dawei Zou, Andy Gu, Wenhao Chen · 2021 · Frontiers in Immunology
79. Phenotypic CD8 T cell profiling in chronic hepatitis B to predict HBV-specific CD8 T cell susceptibility to functional restoration in vitro
    Marzia Rossi, Andrea Lorenzo Vecchi, Camilla Tiezzi, Valeria Barili, Paola Fisicaro, Amalia Penna, Ilaria Montali, Stéphane Daffis, Simon P. Fletcher, Anuj Gaggar et al. · 2023 · Gut
80. Exhausted T cells hijacking the cancer-immunity cycle: Assets and liabilities
    Anna E. Brunell, Riitta Lahesmaa, Anu K Autio, Anil K. Thotakura · 2023 · Frontiers in Immunology
81. Lymph nodes: at the intersection of cancer treatment and progression
    Nathan Edward Reticker-Flynn, Edgar G. Engleman · 2023 · Trends in Cell Biology
82. Strategies to overcome HBV-specific T cell exhaustion: checkpoint inhibitors and metabolic re-programming
    Paola Fisicaro, Carolina Boni, Valeria Barili, Diletta Laccabue, Carlo I. Ferrari · 2018 · Current Opinion in Virology
83. Immune Exhaustion: Past Lessons and New Insights from Lymphocytic Choriomeningitis Virus
    Shannon M. Kahan, Allan J Zajac · 2019 · Viruses
84. Critical role of post-transcriptional regulation for IFN-γ in tumor-infiltrating T cells
    Fiamma Salerno, Aurélie Guislain, Julian J. Freen‐van Heeren, Benoît P. Nicolet, Howard A. Young, Monika C. Wolkers · 2018 · OncoImmunology
85. Regulation of PD-1 in T cells for cancer immunotherapy
    Xibao Yu, Rili Gao, Yangqiu Li, Chengwu Zeng · 2020 · European Journal of Pharmacology
86. Reversing Post-Infectious Epigenetic-Mediated Immune Suppression
    Abhimanyu Abhimanyu, Carlos Oscar Ontiveros, Rosa Selenia Guerra-Resendez, Tomoki Nishiguchi, Malik Ladki, Isaac B. Hilton, Larry S. Schlesinger, Andrew R. DiNardo · 2021 · Frontiers in Immunology
87. Dynamic Transcriptional and Epigenetic Changes Drive Cellular Plasticity in the Liver
    Merrell, Allyson J., Peng, Tao, Li, Jinyang, Sun, Kathryn, Li, Bin, Katsuda, Takeshi, Grompe, Markus, Tan, Kai, Stanger, Ben Z. · 2021 · Hepatology
88. Exhausted T cells in systemic lupus erythematosus patients in long-standing remission
    Guadalupe Lima, Francisco Treviño-Tello, Yemil Atisha‐Fregoso, Luis Llorente, Hilda Esther Fragoso-Loyo, Juan Jakez‐Ocampo · 2021 · Clinical & Experimental Immunology
89. β-catenin and PI3Kδ inhibition expands precursor Th17 cells with heightened stemness and antitumor activity
    Kinga Majchrzak, Michelle Hase Nelson, Jacob S. Bowers, Stefanie R. Bailey, Megan M. Wyatt, John M. Wrangle, Mark P. Rubinstein, Juan Carlos Varela, Zihai Li, Richard A. Himes et al. · 2017 · JCI Insight
90. Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
    Samantha L. Bucktrout, Jeffrey A. Bluestone, Fred Ramsdell · 2018 · Genome Medicine
91. Calcium phosphate nanoneedle based gene delivery system for cancer genetic immunotherapy
    Jing Zhao, Guochuang Chen, Xiaojuan Pang, Peifa Zhang, Xiaohu Hou, Ping Chen, Yi-Wu Xie, Chengyi He, Zhiyong Wang, Zhiying Chen · 2020 · Biomaterials
92. T-cell dysfunction in chronic lymphocytic leukemia from an epigenetic perspective
    Fleur S. Peters, Jonathan C. Strefford, Eric Eldering, Arnon Philip Kater · 2021 · Haematologica
93. HMGB2 regulates the differentiation and stemness of exhausted CD8+ T cells during chronic viral infection and cancer
    Emily N. Neubert, Julia M. DeRogatis, Sloan A. Lewis, Karla M. Viramontes, Pedro Ortega, Monique L. Henriquez, Rémi Buisson, Ilhem Messaoudi, Roberto Tinoco · 2023 · Nature Communications
94. The malate shuttle detoxifies ammonia in exhausted T cells by producing 2-ketoglutarate
    Nina Weisshaar, Sicong Ma, Yanan Ming, Alaa Madi, Alessa Mieg, Marvin Hering, Ferdinand Zettl, Kerstin Möhr, Nora ten Bosch, Diana Stichling et al. · 2023 · Nature Immunology
95. Enhancing anti-tumor immune responses through combination therapies: epigenetic drugs and immune checkpoint inhibitors
    Ying Jie Liang, Lingling Wang, Peijun Ma, Dongen Ju, Ming Zhao, Yun Shi · 2023 · Frontiers in Immunology
96. CD8-Targeted IL2 Unleashes Tumor-Specific Immunity in Human Cancer Tissue by Reviving the Dysfunctional T-cell Pool
    Paulien Kaptein, Nadine Slingerland, Christina Metoikidou, Felix Prinz, Simone Brokamp, Mercedes Machuca-Ostos, Guido de Roo, Ton N. Schumacher, Yik Andy Yeung, Kelly Dare Moynihan et al. · 2024 · Cancer Discovery
97. T cell exhaustion in human cancers
    Kuan Kang, Xin Lin, Pan Chen, Huai Liu, Feng Liu, Wei Xiong, Guiyuan Li, Mei Yi, Xiayu Li, Hui Wang et al. · 2024 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
98. E2A-regulated epigenetic landscape promotes memory CD8 T cell differentiation
    Schauder, David M., Shen, Jian, Chen, Yao, Kasmani, Moujtaba Y., Kudek, Matthew R., Burns, Robert, Cui, Weiguo · 2021 · Proceedings of the National Academy of Sciences
99. Strength in diversity: Phenotypic, functional, and molecular heterogeneity within the memory B cell repertoire
    Kim L. Good‐Jacobson · 2018 · Immunological Reviews
100. The expression of MHC class II molecules on murine breast tumors delays T-cell exhaustion, expands the T-cell repertoire, and slows tumor growth
     Tyler R. McCaw, Mei Li, Dmytro Starenki, Sara J. Cooper, Mingyong Liu, Selene Meza‐Perez, Rebecca Christian Arend, Donald J. Buchsbaum, Andres Forero, Troy D. Randall · 2018 · Cancer Immunology Immunotherapy